Press Release Aug 31 2020
Filed with NSE · · 3 pages · English
Summary by 6ix AI
Wockhardt Limited has announced the appointment of Mr. Akhilesh Gupta as an Additional Director on its Board, effective from a recent date. The company believes that his diverse background will strengthen the Board and enhance its capabilities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Wockhardt
- Press Release Aug 29 2020
- Press Release Aug 03 2020
- Wockhardt receives US FDA Qualified Infectious Disease Product designation for WCK 6777, a first ever once-a-day -lactam enhancer class antibiotic
- Wockhardt receives ANDA approval for pain medication Oxycodone liquid
- Wockhardt: Wockhardt launches generic version of anti-convulsant drug Lamictal XR
Later from Wockhardt
- Press Release Nov 02 2020
- Press Release Dec 01 2020
- Press Release Jan 29 2021
- Press Release Feb 10 2021
- Press Release May 27 2021
Follow Wockhardt into a list and get an email when it puts out news.
Follow Wockhardt